1. Placebos and blinding in randomized controlled cancer clinical trials for drug and biological products Publication: Silver Spring, MD : Center for Drug Evaluation and Research, August 2019 Subject(s): Double-Blind MethodNeoplasms -- drug therapyPlacebosRandomized Controlled Trials as Topic -- standardsSingle-Blind MethodAntineoplastic AgentsBiological ProductsRandomized Controlled Trials as Topic -- ethicsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Clinical trial imaging endpoint process standards Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 2018 Subject(s): Clinical Trials as Topic -- standardsDiagnostic Imaging -- standardsEndpoint Determination -- standardsResearch Design -- standardsObserver VariationSingle-Blind MethodHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Use of electronic health record data in clinical investigations Publication: Silver Spring, MD : Center for Drug Evaluation and Research, July 2018 Subject(s): Clinical Trials as TopicElectronic Health Records -- utilizationHealth Information InteroperabilityForms and Records ControlInformed ConsentReproducibility of ResultsSingle-Blind MethodHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
4. Allergic rhinitis: developing drug products for treatment Publication: Silver Spring, MD : Center for Drug Evaluation and Research, September 2018 Subject(s): Clinical Trials as TopicDrug EvaluationRhinitis, Allergic -- drug therapyAdrenal Cortex Hormones -- therapeutic useAdultChildDrug CombinationsResearch DesignSingle-Blind MethodHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
